In conclusion, our study provided preliminary evidence that the ERCC2 rs50872 T allele was associated with a favorable survival while the XRCC1 rs25487 A allele was associated with a worse survival outcome for advanced NSCLC patients. Here, ERCC2 is linked to non-small cell lung carcinoma.